Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide
Bruno Permanne(Ono Pharmaceutical (United States)), Claudio Soto(The University of Texas Health Science Center at Houston), Céline Adessi, Jo Van Dorpe(Ghent University Hospital), William A. Banks(VA Puget Sound Health Care System), Ilse Dewachter(Hasselt University), Fred Van Leuven(KU Leuven), Gabriela P. Saborı́o(Ono Pharmaceutical (United States)), Marie‐José Frossard(Ono Pharmaceutical (United States)), Santiago Fraga(Instituto Español de Oceanografía)
Cited by 217
Related Papers
Hallmarks of neurodegenerative diseases
|Cell|2023|1.6k
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
|JAMA Neurology|2019|876
Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622